SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-186969
Filing Date
2010-08-12
Accepted
2010-08-12 12:43:51
Documents
9
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1096269
2 AMENDMENT NO. 1 DATED NOVEMBER 11, 2009 TO SUBLEASE AGREEMENT dex10122.htm EX-10.12.2 9967
3 AMENDMENT NO. 2 DATED FEBRUARY 19, 2010 TO SUBLEASE AGREEMENT dex10123.htm EX-10.12.3 22452
4 LIST OF SUBDIDIARIES OF MYRIAD GENETICS, INC. dex211.htm EX-21.1 2558
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 3926
6 CERTIFICATION OF THE CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 9126
7 CERTIFICATION OF THE CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 9106
8 CERTIFICATION OF THE CEO & CFO PURSUANT TO SECTION 906 dex32.htm EX-32 4157
9 GRAPHIC g26850g70w72.jpg GRAPHIC 51258
  Complete submission text file 0001193125-10-186969.txt   1229694
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-26642 | Film No.: 101010324
SIC: 2835 In Vitro & In Vivo Diagnostic Substances